Gastric Antisecretory Drug Market Insights, Global Outlook and Forecast 2022-2028
Gastric Antisecretory Drug Market Insights, Global Outlook and Forecast 2022-2028
Discover the latest insights into the booming Gastric Antisecretory Drug Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Both histamine H2-receptor antagonists and gastric proton pump inhibitors are now world-widely used as the first choice for the treatment of acid-related diseases.
The latest research study released by Market IntelliX evaluates market size and forecasts of Gastric Antisecretory Drug in global, including the following market information:
Global Gastric Antisecretory Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastric Antisecretory Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gastric Antisecretory Drug companies in 2021 (%)
The global Gastric Antisecretory Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
H2-receptor Antagonists Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastric Antisecretory Drug include Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda and NCPC and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Gastric Antisecretory Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Gastric Antisecretory Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, by Type, 2021 (%)
H2-receptor Antagonists
Gastric Proton Pump Inhibitors
Others
Global Gastric Antisecretory Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, by Application, 2021 (%)
Dyspepsia
Peptic Ulcer
Gastroesophageal Reflux
Others
Global Gastric Antisecretory Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Antisecretory Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastric Antisecretory Drug revenues share in global market, 2021 (%)
Key companies Gastric Antisecretory Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gastric Antisecretory Drug sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Bayer
Cadila Pharmaceuticals
AstraZeneca
Jiangsu Aosaikang
Eisai
Pfizer
Altana Pharma
Takeda
NCPC
Luoxin
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Gastric Antisecretory Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastric Antisecretory Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastric Antisecretory Drug Overall Market Size
2.1 Global Gastric Antisecretory Drug Market Size: 2021 VS 2028
2.2 Global Gastric Antisecretory Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gastric Antisecretory Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Gastric Antisecretory Drug Players in Global Market
3.2 Top Global Gastric Antisecretory Drug Companies Ranked by Revenue
3.3 Global Gastric Antisecretory Drug Revenue by Companies
3.4 Global Gastric Antisecretory Drug Sales by Companies
3.5 Global Gastric Antisecretory Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gastric Antisecretory Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gastric Antisecretory Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastric Antisecretory Drug Players in Global Market
3.8.1 List of Global Tier 1 Gastric Antisecretory Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastric Antisecretory Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastric Antisecretory Drug Market Size Markets, 2021 & 2028
4.1.2 H2-receptor Antagonists
4.1.3 Gastric Proton Pump Inhibitors
4.1.4 Others
4.2 By Type - Global Gastric Antisecretory Drug Revenue & Forecasts
4.2.1 By Type - Global Gastric Antisecretory Drug Revenue, 2017-2022
4.2.2 By Type - Global Gastric Antisecretory Drug Revenue, 2023-2028
4.2.3 By Type - Global Gastric Antisecretory Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Gastric Antisecretory Drug Sales & Forecasts
4.3.1 By Type - Global Gastric Antisecretory Drug Sales, 2017-2022
4.3.2 By Type - Global Gastric Antisecretory Drug Sales, 2023-2028
4.3.3 By Type - Global Gastric Antisecretory Drug Sales Market Share, 2017-2028
4.4 By Type - Global Gastric Antisecretory Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Gastric Antisecretory Drug Market Size, 2021 & 2028
5.1.2 Dyspepsia
5.1.3 Peptic Ulcer
5.1.4 Gastroesophageal Reflux
5.1.5 Others
5.2 By Application - Global Gastric Antisecretory Drug Revenue & Forecasts
5.2.1 By Application - Global Gastric Antisecretory Drug Revenue, 2017-2022
5.2.2 By Application - Global Gastric Antisecretory Drug Revenue, 2023-2028
5.2.3 By Application - Global Gastric Antisecretory Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Gastric Antisecretory Drug Sales & Forecasts
5.3.1 By Application - Global Gastric Antisecretory Drug Sales, 2017-2022
5.3.2 By Application - Global Gastric Antisecretory Drug Sales, 2023-2028
5.3.3 By Application - Global Gastric Antisecretory Drug Sales Market Share, 2017-2028
5.4 By Application - Global Gastric Antisecretory Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Gastric Antisecretory Drug Market Size, 2021 & 2028
6.2 By Region - Global Gastric Antisecretory Drug Revenue & Forecasts
6.2.1 By Region - Global Gastric Antisecretory Drug Revenue, 2017-2022
6.2.2 By Region - Global Gastric Antisecretory Drug Revenue, 2023-2028
6.2.3 By Region - Global Gastric Antisecretory Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Gastric Antisecretory Drug Sales & Forecasts
6.3.1 By Region - Global Gastric Antisecretory Drug Sales, 2017-2022
6.3.2 By Region - Global Gastric Antisecretory Drug Sales, 2023-2028
6.3.3 By Region - Global Gastric Antisecretory Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gastric Antisecretory Drug Revenue, 2017-2028
6.4.2 By Country - North America Gastric Antisecretory Drug Sales, 2017-2028
6.4.3 US Gastric Antisecretory Drug Market Size, 2017-2028
6.4.4 Canada Gastric Antisecretory Drug Market Size, 2017-2028
6.4.5 Mexico Gastric Antisecretory Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gastric Antisecretory Drug Revenue, 2017-2028
6.5.2 By Country - Europe Gastric Antisecretory Drug Sales, 2017-2028
6.5.3 Germany Gastric Antisecretory Drug Market Size, 2017-2028
6.5.4 France Gastric Antisecretory Drug Market Size, 2017-2028
6.5.5 U.K. Gastric Antisecretory Drug Market Size, 2017-2028
6.5.6 Italy Gastric Antisecretory Drug Market Size, 2017-2028
6.5.7 Russia Gastric Antisecretory Drug Market Size, 2017-2028
6.5.8 Nordic Countries Gastric Antisecretory Drug Market Size, 2017-2028
6.5.9 Benelux Gastric Antisecretory Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gastric Antisecretory Drug Revenue, 2017-2028
6.6.2 By Region - Asia Gastric Antisecretory Drug Sales, 2017-2028
6.6.3 China Gastric Antisecretory Drug Market Size, 2017-2028
6.6.4 Japan Gastric Antisecretory Drug Market Size, 2017-2028
6.6.5 South Korea Gastric Antisecretory Drug Market Size, 2017-2028
6.6.6 Southeast Asia Gastric Antisecretory Drug Market Size, 2017-2028
6.6.7 India Gastric Antisecretory Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gastric Antisecretory Drug Revenue, 2017-2028
6.7.2 By Country - South America Gastric Antisecretory Drug Sales, 2017-2028
6.7.3 Brazil Gastric Antisecretory Drug Market Size, 2017-2028
6.7.4 Argentina Gastric Antisecretory Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastric Antisecretory Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gastric Antisecretory Drug Sales, 2017-2028
6.8.3 Turkey Gastric Antisecretory Drug Market Size, 2017-2028
6.8.4 Israel Gastric Antisecretory Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Gastric Antisecretory Drug Market Size, 2017-2028
6.8.6 UAE Gastric Antisecretory Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Gastric Antisecretory Drug Major Product Offerings
7.1.4 Bayer Gastric Antisecretory Drug Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Key News
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Corporate Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Gastric Antisecretory Drug Major Product Offerings
7.2.4 Cadila Pharmaceuticals Gastric Antisecretory Drug Sales and Revenue in Global (2017-2022)
7.2.5 Cadila Pharmaceuticals Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Gastric Antisecretory Drug Major Product Offerings
7.3.4 AstraZeneca Gastric Antisecretory Drug Sales and Revenue in Global (2017-2022)
7.3.5 AstraZeneca Key News
7.4 Jiangsu Aosaikang
7.4.1 Jiangsu Aosaikang Corporate Summary
7.4.2 Jiangsu Aosaikang Business Overview
7.4.3 Jiangsu Aosaikang Gastric Antisecretory Drug Major Product Offerings
7.4.4 Jiangsu Aosaikang Gastric Antisecretory Drug Sales and Revenue in Global (2017-2022)
7.4.5 Jiangsu Aosaikang Key News
7.5 Eisai
7.5.1 Eisai Corporate Summary
7.5.2 Eisai Business Overview
7.5.3 Eisai Gastric Antisecretory Drug Major Product Offerings
7.5.4 Eisai Gastric Antisecretory Drug Sales and Revenue in Global (2017-2022)
7.5.5 Eisai Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Gastric Antisecretory Drug Major Product Offerings
7.6.4 Pfizer Gastric Antisecretory Drug Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 Altana Pharma
7.7.1 Altana Pharma Corporate Summary
7.7.2 Altana Pharma Business Overview
7.7.3 Altana Pharma Gastric Antisecretory Drug Major Product Offerings
7.7.4 Altana Pharma Gastric Antisecretory Drug Sales and Revenue in Global (2017-2022)
7.7.5 Altana Pharma Key News
7.8 Takeda
7.8.1 Takeda Corporate Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Gastric Antisecretory Drug Major Product Offerings
7.8.4 Takeda Gastric Antisecretory Drug Sales and Revenue in Global (2017-2022)
7.8.5 Takeda Key News
7.9 NCPC
7.9.1 NCPC Corporate Summary
7.9.2 NCPC Business Overview
7.9.3 NCPC Gastric Antisecretory Drug Major Product Offerings
7.9.4 NCPC Gastric Antisecretory Drug Sales and Revenue in Global (2017-2022)
7.9.5 NCPC Key News
7.10 Luoxin
7.10.1 Luoxin Corporate Summary
7.10.2 Luoxin Business Overview
7.10.3 Luoxin Gastric Antisecretory Drug Major Product Offerings
7.10.4 Luoxin Gastric Antisecretory Drug Sales and Revenue in Global (2017-2022)
7.10.5 Luoxin Key News
8 Global Gastric Antisecretory Drug Production Capacity, Analysis
8.1 Global Gastric Antisecretory Drug Production Capacity, 2017-2028
8.2 Gastric Antisecretory Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastric Antisecretory Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastric Antisecretory Drug Supply Chain Analysis
10.1 Gastric Antisecretory Drug Industry Value Chain
10.2 Gastric Antisecretory Drug Upstream Market
10.3 Gastric Antisecretory Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastric Antisecretory Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Gastric Antisecretory Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|